Daily Markup

mClinica

Daily Markup #172: Pandemic preparedness training for 9,000 pharmacy professionals at their fingertips; Can plant-based brands finally compete with meat options on equal ground?; Singaporean tech startups to develop proof-of-concept in 6 months instead of 2–3 years
Daily
Tags: , ,

Daily Markup #172: Pandemic preparedness training for 9,000 pharmacy professionals at their fingertips; Can plant-based brands finally compete with meat options on equal ground?; Singaporean tech startups to develop proof-of-concept in 6 months instead of 2–3 years

Prep on an app 500-backed digital health startup mClinica partnered with several organizations to...
January 14, 2021 · 6 min read

Daily Markup

  • Daily Markup is brought to you by 500 Southeast Asia & 500 Global

  • This website is updated as of August 3, 2022. All content herein is intended solely for general informational or educational purposes only. 500 Startups Management Company, L.L.C. and its affiliates (collectively “500 Startups”) makes no representation as to the accuracy or information in this post and while reasonable steps have been taken to ensure that the information herein is accurate and up-to-date, no liability can be accepted for any error or omissions. All third party links in this post have not been independently verified by 500 Startups and the inclusion of such links should not be interpreted as an endorsement or confirmation of the content within. Information about portfolio companies’ markets, competitors, performance, and fundraising has been provided by those companies’ founders and has not been independently verified. Under no circumstances should any content in this post be construed as investment, legal, tax or accounting advice by 500 Startups, or an offer to provide any investment advisory service with regard to securities by 500 Startups. No content or information in this post should be construed as an offer to sell or solicitation of interest to purchase any securities advised by 500 Startups. Prospective investors considering an investment into any 500 Startups fund should not consider or construe this content as fund marketing material. The views expressed herein are as at the date of this post and are subject to change without notice. One or more 500 Startups fund may have a financial interest in one or more of the companies discussed

    All users of this website should note these important Terms of Use governing the use of this website.

  • Copyright © 2022 500 Global | All Rights Reserved

  • Privacy Policy
    Terms of Use
    Code of Conduct